ஆண்டு அமெரிக்கன் சங்கம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆண்டு அமெரிக்கன் சங்கம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆண்டு அமெரிக்கன் சங்கம் Today - Breaking & Trending Today

Chiasma Inc. (NASDAQ:CHMA) - Chiasma's Mycapssa Associated With Positive Patient-Reported Outcomes In Acromegaly Patients

Chiasma Inc. (NASDAQ:CHMA) - Chiasma's Mycapssa Associated With Positive Patient-Reported Outcomes In Acromegaly Patients
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

United States , American Association Of Clinical Endocrinology Meeting , Chiasma Inc , Annual American Association , Clinical Endocrinology , ஒன்றுபட்டது மாநிலங்களில் , ஆண்டு அமெரிக்கன் சங்கம் , மருத்துவ உட்சுரப்பியல் ,

Chiasma to Present Encore and New Data from MPOWERED™ Phase

New clinical data accepted for oral and e-Poster presentation at AACE e-ECE clinical data previously presented at Endocrine Society’s 2021. ....

United States , Patrick Bursey , Murrayb Gordon , Pamela Freda , Ashley Robinson , Anthonyp Heaney , Maria Fleseriu , Nienke Biermasz , European Congress , Lifesci Advisors , Endocrine Society , Large International Noninferiority Trial , Chiasma Inc , Columbia University , Exchange Commission , Lifesci Communications , Leiden University Medical Center , American Association Of Clinical Endocrinology , Pituitary Center , Corporate Communications , European Union , Annual American Association , Clinical Endocrinology , International Noninferiority Trial , Assessing Maintenance , Oral Octreotide Capsules ,

Chiasma Presents Positive Patient-Reported Outcomes Data from its MPOWERED™ Phase 3 Trial Comparing MYCAPSSA® to Long-Acting Injectables for the Maintenance Treatment of Adults with Acromegaly

Message :
Required fields
NEEDHAM, Mass., May 27, 2021 (GLOBE NEWSWIRE) Chiasma, Inc. (NASDAQ: CHMA), (“Chiasma” or the “Company”) today presented patient-reported outcomes (PROs) data from its MPOWERED™ Phase 3 trial demonstrating that study patients with acromegaly reported significantly improved quality of life and work productivity after transitioning from long-acting injectable somatostatin analogs (iSSAs) to MYCAPSSA
®. The data were shared as an oral presentation at the 30
th Annual American Association of Clinical Endocrinology (AACE) Meeting being held virtually from May 26-29, 2021.
“The encouraging PROs data from the MPOWERED study further our understanding of the potential positive clinical impact that MYCAPSSA has for patients with acromegaly,” said Nienke Biermasz, M.D., Ph.D., Presenting Author. “These PROs provide important information to help physicians assess disease and treatment burden for patients treated with iSSAs and ....

United States , Patrick Bursey , William Ludlam , Ashley Robinson , Nienke Biermasz , Lifesci Advisors , Chiasma Inc , Affairs Of Chiasma , Exchange Commission , Health Problem , American Association Of Clinical Endocrinology , Lifesci Communications , European Union , Corporate Communications , Clinical Development , Annual American Association , Clinical Endocrinology , Work Productivity , Activity Impairment Questionnaire , Specific Health Problem , Vice President , Medical Affairs , Important Safety Information , Prescribing Information , Transient Permeability Enhancer , Private Securities Litigation Reform Act ,

Chiasma to Present Encore and New Data from MPOWERED™ Phase

AACE
e-ECE clinical data previously presented at Endocrine Society’s 2021 annual meeting
NEEDHAM, Mass., May 20, 2021 (GLOBE NEWSWIRE) Chiasma, Inc. (NASDAQ: CHMA), (“Chiasma” or the “Company”), a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral therapies to improve the lives of patients with rare diseases currently treated with burdensome and painful injections, today announced that it will virtually present encore data from its MPOWERED™ Phase 3 clinical trial at the 23
rd European Congress of Endocrinology (e-ECE) (May 22-26, 2021) and new data from the MPOWERED trial at the 30
th Annual American Association of Clinical Endocrinology (AACE) Meeting (May 26-29, 2021). ....

United States , Patrick Bursey , Murrayb Gordon , Pamela Freda , Ashley Robinson , Anthonyp Heaney , Maria Fleseriu , Nienke Biermasz , European Congress , Lifesci Advisors , Endocrine Society , Large International Noninferiority Trial , Chiasma Inc , Columbia University , Exchange Commission , Lifesci Communications , Leiden University Medical Center , American Association Of Clinical Endocrinology , Pituitary Center , Corporate Communications , European Union , Annual American Association , Clinical Endocrinology , International Noninferiority Trial , Assessing Maintenance , Oral Octreotide Capsules ,

Chiasma to Present Encore and New Data from MPOWERED™ Phase 3 Trial at Upcoming e-ECE and AACE Virtual Conferences

Chiasma to Present Encore and New Data from MPOWERED™ Phase 3 Trial at Upcoming e-ECE and AACE Virtual Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Murrayb Gordon , Pamela Freda , Patrick Burseylifesci , Anthonyp Heaney , Maria Fleseriu , Nienke Biermasz , European Congress , Endocrine Society , Columbia University Session Date Time , Large International Noninferiority Trial , Chiasma Inc , Exchange Commission , Leiden University Medical Center Session Date Time , American Association Of Clinical Endocrinology , Corporate Communications , European Union , Leiden University Medical Centersession Date Time , Annual American Association , Clinical Endocrinology , International Noninferiority Trial , Assessing Maintenance , Oral Octreotide Capsules , Injectable Somatostatin Receptor Ligandspresenter , Neurological Surgery , Pituitary Centersession ,